Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1993;21:739-744

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuchihashi, T.
Right arrow Articles by Averill, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuchihashi, T.
Right arrow Articles by Averill, D. B.

Hypertension, Vol 21, 739-744, Copyright © 1993 by American Heart Association


ARTICLES

Metabotropic glutamate receptors in the ventrolateral medulla of rats

T Tsuchihashi and DB Averill
Department of Brain and Vascular Research, Cleveland Clinic Foundation, Ohio.

We investigated the hypothesis that stimulation of metabotropic excitatory amino acid receptors in the ventrolateral medulla evokes cardiovascular responses. Thus, (1S,3R)-1-aminocyclopentane-1,3- dicarboxylic acid [(1S,3R)-ACPD], a selective agonist of metabotropic excitatory amino acid receptors, was microinjected into the rostral or caudal ventrolateral medulla of halothane-anesthetized Sprague-Dawley rats. Microinjections of (1S,3R)-ACPD (100 pmol-1 nmol) into the rostral ventrolateral medulla produced dose-dependent increases in mean arterial pressure (+20 +/- 4 mm Hg by 100 pmol and +35 +/- 2 mm Hg by 1 nmol, p < 0.01 versus artificial cerebrospinal fluid) and integrated splanchnic sympathetic nerve activity (+17 +/- 3% and +46 +/- 4%, respectively, p < 0.01), whereas (1S,3+)-ACPD microinjected into the caudal ventrolateral medulla decreased mean arterial pressure (-28 +/- 2 mm Hg by 100 pmol and -48 +/- 6 mm Hg by 1 nmol, p < 0.01 versus artificial cerebrospinal fluid) and splanchnic sympathetic nerve activity (-24 +/- 4% and -49 +/- 5%, p < 0.01). The blockade of ionotropic excitatory amino acid receptors by the combined injection of 2-amino-7-phosphonoheptanoic acid (200 pmol) and 6,7-dinitroquinoxaline- 2,3-dione (200 pmol), which effectively blocked the responses elicited by either N-methyl-D-aspartate (20 pmol) or alpha-amino-3-hydroxy-5- methylisoxazole-4-propionic acid (5 pmol), failed to affect the responses evoked by either (1S,3R)-ACPD (100 pmol) or L-glutamate (2 nmol) microinjected in the rostral and caudal ventrolateral medulla. These results suggest that metabotropic receptors are present and mediate cardiovascular responses evoked by L-glutamate injections into the rostral and caudal ventrolateral medulla.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. N. Mayorov and G. A. Head
Glutamate receptors in RVLM modulate sympathetic baroreflex in conscious rabbits
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R511 - R519.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W.-B. Len and J. Y. H. Chan
Glutamatergic projection to RVLM mediates suppression of reflex bradycardia by parabrachial nucleus
Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1482 - H1492.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. J. Ohtake, J. E. Torres, Y. M. Gozal, G. R. Graff, and D. Gozal
NMDA receptors mediate peripheral chemoreceptor afferent input in the conscious rat
J Appl Physiol, March 1, 1998; 84(3): 853 - 861.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Tsuchihashi, S. Kagiyama, Y. Ohya, I. Abe, and M. Fujishima
Antihypertensive Treatment and the Responsiveness to Glutamate in Ventrolateral Medulla
Hypertension, January 1, 1998; 31(1): 73 - 76.
[Abstract] [Full Text] [PDF]